Molecular dynamics simulations exploring drug resistance in HIV-1 proteases

被引:0
作者
GU Hui CHEN HaiFeng WEI DongQing WANG JingFang College of Life Sciences and BiotechnologyShanghai Jiaotong UniversityShanghai ChinaShanghai Centre for Systems BiomedicineShanghai Jiaotong UniversityShanghai China Shanghai Centre for Bioinformation TechnologyShanghai China [1 ,1 ,1 ,2 ,3 ,1 ,200240 ,2 ,200240 ,3 ,200035 ]
机构
关键词
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Although HIV-1 subtype B still dominates the epidemic AIDS in developed countries,an increasing number of people in developing countries are suffering from an epidemic of non-subtype B viruses.What is worse,the efficacy of the combinational use of antiretroviral drugs is gradually compromised by the rapid development of drug resistance.To gain an insight into drug resistance, 10-ns MD simulations were simultaneously conducted on the complexes of the TL-3 inhibitor with 4 different proteases(Bwt,Bmut, Fwt and Fmut),among which the complex of the Bwt protease with the TL-3 inhibitor was treated as the control group.Detailed analyses of MD data indicated that the drug resistance of Bmut against TL-3 mainly derived from loss of an important hydrogen bond and that of Fwt was caused by the decrease of hydrophobic interactions in S1/S1'pocket,while both of the two reasons mentioned above were the cause of the Fmut protease's resistance.These results are in good agreement with the previous experiments, revealing a possible mechanism of drug resistance for the aforementioned protease subtypes against the TL-3 inhibitor.Additionally,another indication was obtained that the mutations of M36I,V82A and L90M may induce structural transforms so as to alter the inhibitor's binding mode.
引用
收藏
页码:2677 / 2683
页数:7
相关论文
共 50 条
[21]   Computational simulations of HIV-1 proteases-multi-drug resistance due to nonactive site mutation L90M [J].
Ode, Hirotaka ;
Neya, Saburo ;
Hata, Masayuki ;
Sugiura, Wataru ;
Hoshino, Tyuji .
Journal of the American Chemical Society, 2006, 128 (24) :7887-7895
[22]   Dynamics of Transmitted HIV-1 Drug Resistance - The San Francisco Model [J].
Abecasis, Ana B. ;
Mueller, Viktor .
AIDS REVIEWS, 2010, 12 (02) :122-123
[23]   DYNAMICS BEHAVIOR OF MUTATION DURING REPRODUCTION ON HIV-1 DRUG RESISTANCE [J].
Huang, Guangyu ;
Fan, Aijun ;
Wang, Kaifa .
INTERNATIONAL JOURNAL OF BIOMATHEMATICS, 2013, 6 (03)
[24]   HIV-1 Diversity, Transmission Dynamics and Primary Drug Resistance in Angola [J].
Bartolo, Ines ;
Zakovic, Suzana ;
Martin, Francisco ;
Palladino, Claudia ;
Carvalho, Patricia ;
Camacho, Ricardo ;
Thamm, Sven ;
Clemente, Sofia ;
Taveira, Nuno .
PLOS ONE, 2014, 9 (12)
[25]   Restrained molecular dynamics simulations of HIV-1 protease: The first step in validating a new target for drug design [J].
Perryman, AL ;
Lin, JH ;
McCammon, JA .
BIOPOLYMERS, 2006, 82 (03) :272-284
[26]   Antiretroviral drug resistance in HIV-1 [J].
George J. Hanna ;
Richard T. D’Aquila .
Current Infectious Disease Reports, 1999, 1 (3) :289-297
[27]   Testing for HIV-1 drug resistance [J].
Hanna, GJ ;
Caliendo, AM .
MOLECULAR DIAGNOSIS, 2001, 6 (04) :253-263
[28]   Mechanisms of HIV-1 drug resistance [J].
Larder, B .
AIDS, 2001, 15 :S27-S34
[29]   Understanding HIV-1 drug resistance [J].
Frenkel, LM ;
Tobin, NH .
THERAPEUTIC DRUG MONITORING, 2004, 26 (02) :116-121
[30]   Transmission of HIV-1 drug resistance [J].
Tang, JW ;
Pillay, D .
JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (01) :1-10